CClinicalTrials.gg
WithdrawnNCT01615536CFTUpdated Jan 10, 2014

The Role of Canine Fossa Trephination in the Severely Diseased Maxillary Sinus

An interventional study of Canine fossa trephine technique and Standard Endoscopic Sinus Surgery in Disorder of Maxillary Sinus, Aspirin-sensitive Asthma With Nasal Polyps and Rhinosinusitis, sponsored by IWitterick. Withdrawn at 1 site in Canada. Open to participants aged 18 Years to 70 Years. Per ClinicalTrials.gov, last updated 2014-01-10.

Sponsored by IWitterick · Not applicable, Interventional, and Treatment

Why this study was withdrawn
Inability to recruit subjects
Phase
Not applicable
Study type
Interventional
Enrollment
0
Allocation
Randomized
Ages
18 Years to 70 Years
Sex
All
01

Study summary

The hypothesis of this study is that canine fossa trephination (CFT) improves surgical outcomes for patients with a severely diseased maxillary sinus.

Read the detailed description

Chronic sinusitis (CRS) with nasal polyps and thick mucin in the sinuses adversely affects results from endoscopic sinus surgery (ESS) because failure to clear the disease leads to ongoing inflammation and symptoms. In particular a subset of CRS patients with thick eosinophilic mucin (EMCRS) develop recurrent symptoms and require further surgeries. ESS techniques for the maxillary sinus requires a WMA in the side wall of the sinus and the use of curved debrider instruments to clear the polyps. Sometimes this doesn't provide access to the inferior/floor and anterior/front aspects of the maxillary sinus due to the fact that the maxillary sinus is on the side of the nasal cavity at an angle. The CFT through the front wall of the sinus was developed years ago as an alternative approach to improve access to these areas. Both techniques are acceptable standard treatments and which one is initially used to address the maxillary sinus currently depends on surgeon preference. The role of CFT has been studied by Sathanatar et al (Laryngoscope 2005) and Lee et al (Laryngoscope 2008) which provided conflicting results. Differences in their study patients and methodology could explain the different outcomes. Hence this study is proposed to clarify the role of CFT in patients with extensive maxillary sinus disease to see whether initial use of CFT is more helpful than WMA in the severely diseased maxillary sinus with polyps and mucin. Findings from this study may improve surgical outcomes for CRS patients in the future.

02

Conditions studied

  • Disorder of Maxillary Sinus
  • Aspirin-sensitive Asthma With Nasal Polyps
  • Rhinosinusitis

Keywords

  • chronic rhinosinusitis
  • canine fossa trephine
  • canine fossa puncture
03

In context

Rhinosinusitis

330 studies on the registry are indexed under Rhinosinusitis; 55 are open to participants now.

Browse Rhinosinusitis studies →

Lead sponsor

This is the only study on the registry with IWitterick as lead sponsor.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 70 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Patients with extensively opacified maxillary sinuses on CT scanning undergoing Endoscopic Sinus Surgery for Chronic Rhinosinusitis
  • Patients with Eosinophilic Mucin Chronic Rhinosinusitis or fungal sinusitis disease undergoing Endoscopic Sinus Surgery for Chronic Rhinosinusitis
  • Patients with Recalcitrant Chronic Rhinosinusitis undergoing Endoscopic Sinus Surgery for Chronic Rhinosinusitis
  • Patients over the age of 18
  • Patients able to give informed consent to participate in the study

Exclusion criteria

Exclusion Criteria:

  • Patients will be excluded if they are unable to undergo surgery due to co morbidities.
  • Patients with previous Caldwell-Luc procedures
  • Patients with pre existing paraesthesia of the upper teeth or gums
  • Patients with destructive lesions of the maxilla
  • Patients with systemic disease affecting the paranasal sinuses (e.g. Wegener's granulomatosis)
  • Patients immune compromised
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
0 participants (actual)

Study arms

  • Experimental
    Canine fossa trephine group (CFT)

    Procedure: Canine fossa trephine technique

  • Active comparator
    Non Canine fossa trephine group (NonCFT)

    Procedure: Standard Endoscopic Sinus Surgery

Interventions

  • ProcedureCanine fossa trephine technique

    Patients undergoing standard ESS and a canine fossa trephine technique, which is a 6 mm puncture in the anterior wall of the maxillary sinus, to allow standard sinus debrider blades and instruments to pass into the sinus to clear polyps in the maxillary sinus.

    Also known as: Canine fossa puncture

  • ProcedureStandard Endoscopic Sinus Surgery

    Patients undergoing standard ESS without canine fossa trephination with clearance of the maxillary sinus polyps via a wide maxillary antrostomy (WMA) with use of curved debrider surgical blades and instruments.

    Also known as: Functional Endoscopic Sinus Surgery

06

What researchers measure

Primary outcomes

  1. Standard validated symptom scores

    1. Chronic sinusitis survey 2. SNOT (Sinonasal Outcome Test)22

    Time frame: 6 months

Secondary outcomes

  1. Ability to completely clear the maxillary sinus of all disease (e.g. polyps and eosinophilic mucus)

    Measured by using a surgeon survey

    Time frame: Measured during surgery

  2. Surgical time spent clearing the maxillary sinus disease between the CFT and non-CFT groups

    Measured in minutes

    Time frame: At the time of surgery

  3. Endoscopy scores

    1. Grade 0: Normal mucosa with no evidence of disease 2. Grade 1: Edematous mucosa and/or eosinophilic mucus 3. Grade 2: Polypoidal mucosa and/or eosinophilic mucus 4. Grade 3: Polyps and fungal debris

    Time frame: Measured at 2,6, 12 months

07

Study locations

1 site
  • Mt Sinai Hospital
    Toronto, Ontario M5G 1H4, Canada
08

References and documents

Publications

  • Sathananthar S, Nagaonkar S, Paleri V, Le T, Robinson S, Wormald PJ. Canine fossa puncture and clearance of the maxillary sinus for the severely diseased maxillary sinus. Laryngoscope. 2005 Jun;115(6):1026-9. doi: 10.1097/01.MLG.0000162651.22019.4A. PubMed 15933514 ↗
  • Lee JY, Lee SH, Hong HS, Lee JD, Cho SH. Is the canine fossa puncture approach really necessary for the severely diseased maxillary sinus during endoscopic sinus surgery? Laryngoscope. 2008 Jun;118(6):1082-7. doi: 10.1097/MLG.0b013e318169028d. PubMed 18388769 ↗
  • Gliklich RE, Metson R. Techniques for outcomes research in chronic sinusitis. Laryngoscope. 1995 Apr;105(4 Pt 1):387-90. doi: 10.1288/00005537-199504000-00010. PubMed 7715384 ↗
  • Singhal D, Douglas R, Robinson S, Wormald PJ. The incidence of complications using new landmarks and a modified technique of canine fossa puncture. Am J Rhinol. 2007 May-Jun;21(3):316-9. doi: 10.2500/ajr.2007.21.3022. PubMed 17621816 ↗
  • Lund VJ, Mackay IS. Staging in rhinosinusitus. Rhinology. 1993 Dec;31(4):183-4. No abstract available. PubMed 8140385 ↗
09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jan 10, 2014, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT01615536
Lead sponsor
IWitterick
Responsible party
IWitterick (Otolaryngologist Head-Neck Surgeon, Samuel Lunenfeld Research Institute, Mount Sinai Hospital) — Sponsor-investigator
First posted
Jun 8, 2012
Start date
Dec 2010
Primary completion
Dec 2013
Completion
Jan 2014
Last update
Jan 10, 2014

Study contacts

Ian J Witterick, MD
principal investigator · MOUNT SINAI HOSPITAL

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is withdrawn, as verified in Jan 2014. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion